Navigating the Patented Medicine Prices Review Board: From Scientific Review to Hearing

Dec. 7, 2017
Toronto Online

CBA Biotech Committee & OBA Information Technology and Intellectual Property LAW PROGRAM | 12:30 PM to 2:30 PM

Regulation under the Patented Medicine Prices Review Board (PMPRB) is a key concern for pharmaceutical companies. With major changes likely coming, ensure you are up to speed on the latest developments and have the expertise you need to advise your pharmaceutical clients with this helpful program. Join us to explore the current landscape and future direction of the PMPRB, including modernization initiatives and Health Canada’s consultations. Our expert faculty will share valuable insights and best practices for engaging with the PMPRB to help you enhance your practice.

To view the full program agenda, please click here.

PROGRAM CHAIRS

Geoff Mowatt, DLA Piper (Canada) LLP
Tracey Stott, Norton Rose Fulbright Canada LLP

PROGRAM SPEAKERS

Jill Daley, Eli Lilly Canada Inc.
Neil Fineberg, Partner, Fineberg.Legal LLP 
Matthew Kellison, Director, Regulatory Affairs & Outreach, PMPRB
Neil Palmer, Founder & Principal Consultant, PDCI Market Access Inc
Kristin Wall, Partner, Norton Rose Fulbright LLP

PROGRAM DETAILS

Date: Thursday, December 7, 2017
Time: 12:30 pm - 2:30 pm Program
 

PROGRAM PRICE

CBA Member: $129* | CBA Student Member: $65* | Non-Member: $225*

*plus applicable taxes

 

printPrint     Bookmark and Share

    OTHER FORMATS AVAILABLE

    This program is also available In Person
     

    Viewer Specifications for Webcast

    Adobe Acrobat Reader 10.0+
    High-speed internet connectionTest
    Modern web browser, e.g. Internet Explorer 11+

 

CONTACT INFO

Ontario Bar Association
Tele: (416) 869-1047
Toll-free in Ontario
1-800-668-8900
E-Mail: registrations@oba.org
Web: www.oba.org